Do mitochondria care about insulin resistance?

Molecular Metabolism

Volumn 3, Issue 4, 2014, Pages 351-353

  Koliaki, Chrysi ^a,b   Roden, Michael ^a,b,c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84902345374     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.04.004     Document Type: Note

References (10)

1. Martin S.D., Morrison S., Konstantopoulos N., McGee S.L. Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action. Molecular Metabolism 2014, [in press].
2. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003, 34:267-273.
3. Misu H., Takamura T., Matsuzawa N., Shimizu A., Ota T., Sakurai M., et al. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 2007, 50:268-277.
4. Zhang D., Liu Z.X., Choi C.S., Tian L., Kibbey R., Dong J., et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:17075-17080.
5. Pospisilik J.A., Knauf C., Joza N., Benit P., Orthofer M., Cani P.D., et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007, 131:476-491.
6. Morino K., Petersen K.F., Dufour S., Befroy D., Frattini J., Shatzkes N., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. The Journal of Clinical Investigation 2005, 115:3587-3593.
7. Szendroedi J., Phielix E., Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nature Reviews. Endocrinology 2012, 8:92-103.
8. Koliaki C., Roden M. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Molecular and Cellular Endocrinology 2013, 379:35-42.
9. Sequaris G., Jelenik T., Phielix E., Kotzka J., Knebel B., Ouwens M., et al. Effects of hyperglycemia on muscular and hepatic mitochondrial function and insulin sensitivity in mice. Diabetes 2012, 61(Suppl.1):A414.
10. Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:8665-8670.